Promising therapies for platinum-resistant ovarian cancer produced mixed results in separate trials. The AKT inhibitor ...

The essential charities supporting trans rights and how you can make a difference, including akt, gendergp, gendered ...

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder with a rapidly increasing global prevalence. It is primarily ...

We won’t rest until every young, LGBT+ person has a safe and secure place to call home with the support they need to go on and thrive as happy and successful adults.

Direct-acting antivirals (DAAs) have dramatically changed the landscape of chronic hepatitis C virus (HCV) treatment and ...

Just recently, the major independent design studio Two Times Elliott closed the doors of its permanent studio space. Founder ...

A host of inspirational individuals, charities and organisations were commended for their work with the LGBTQ+ community at ...

Hepatitis C virus (HCV) infection remains a major global health burden, affecting millions worldwide and contributing significantly to hepatocellular carcinoma (HCC) development.

Adding afuresertib to paclitaxel did not improve outcomes in patients with platinum-resistant ovarian cancer in a phase 2 trial.

Particularly noteworthy among these compounds are 6-gingerol and 6-shogaol, which have been recognized for their potent ...